Internal Medicine, Nephrology · Evansville, IN
NPI
1093715435
Since 2005
Specialty
Internal Medicine, Nephrology
Code 207RN0300X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
3801 Bellemeade Ave Ste 330
Evansville, IN, 47714
Phone (812) 479-3125
Groups this clinician bills Medicare through
Medicare paid, 2024
$139K
1,574 services
Medicare patients, 2024
391
Average age 74
Drug cost, 2024
$1.2M
1,797 prescriptions
Company payments, 2025
$5,073
From 11 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by James A Evanson was code 99232 (hospital e&m - subsequent), 400 times for 129 patients. In total James A Evanson billed 1,574 services in 22 codes, and Medicare paid $139K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2018-04-03.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99232 Hospital E&M - Subsequent | Facility | 400 | 129 | $62.31 | $25K |
| 99214 Office E&M - Established | Office | 373 | 196 | $91.21 | $34K |
| 90970 ESRD Related Services (not dialysis) | Office | 174 | 13 | $7.52 | $1,308 |
| 99213 Office E&M - Established | Office | 159 | 113 | $63.92 | $10K |
| 90935 Hemodialysis | Facility | 107 | 33 | $56.45 | $6,040 |
| 90960 ESRD Related Services (not dialysis) | Office | 102 | 15 | $281.24 | $29K |
| 99204 Office E&M - New | Office | 48 | 48 | $126.96 | $6,094 |
| 90945 Peritoneal Dialysis | Facility | 45 | 15 | $68.05 | $3,062 |
| 99222 Hospital E&M - Initial | Facility | 40 | 34 | $98.81 | $3,952 |
| 99223 Hospital E&M - Initial | Facility | 34 | 32 | $137.39 | $4,671 |
| 99231 Hospital E&M - Subsequent | Facility | 13 | 12 | $38.98 | $507 |
By year: 2022 $160K for 1,681 services; 2023 $133K for 1,404 services; 2024 $139K for 1,574 services.
Medicare prescription drug claims, 2024
In 2024, the drug James A Evanson prescribed most often to Medicare patients was Furosemide, with 150 prescriptions and refills. In total James A Evanson wrote 1,797 Medicare prescriptions that cost $1.2M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Furosemide Generic | 150 | 301 | 49 | $541 |
| Kerendia Finerenone | 126 | 185 | 25 | $119K |
| Losartan Potassium Generic | 119 | 277 | 32 | $771 |
| Amlodipine Besylate Generic | 91 | 215 | 27 | $327 |
| Hydrochlorothiazide Generic | 85 | 223 | 22 | $403 |
| Tamsulosin Hcl Generic | 80 | 184 | 22 | $752 |
| Spironolactone Generic | 74 | 164 | 22 | $567 |
| Allopurinol Generic | 71 | 175 | 18 | $453 |
| Torsemide Generic | 67 | 154 | 21 | $989 |
| Farxiga Dapagliflozin Propanediol | 61 | 100 | 14 | $54K |
| Olmesartan Medoxomil Generic | 57 | 122 | 19 | $482 |
| Potassium Chloride Generic | 43 | 87 | 12 | $1,094 |
| Sevelamer Carbonate Generic | 37 | 61 | 16 | $5,557 |
| Jynarque Tolvaptan | 33 | 33 | Under 11 | $657K |
| Hydralazine Hcl Generic | 32 | 70 | 11 | $750 |
Brand drugs: 343 claims; generic drugs: 1,454 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid James A Evanson $5,073 ($5,073 in general payments such as food, travel and fees) from 11 companies. The largest payer was Bayer Healthcare Pharmaceuticals Inc. with $4,482.
| Company | Payments | Amount |
|---|---|---|
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 18 | $4,482 |
| Travere Therapeutics, Inc. TVTX | 4 | $123 |
| Ardelyx, Inc. ARDX | 3 | $106 |
| AstraZeneca Pharmaceuticals LP AZN | 4 | $70.4 |
| Otsuka America Pharmaceutical, Inc. 4578.T | 3 | $67.22 |
| ANI Pharmaceuticals, Inc. ANIP | 3 | $47.19 |
| Amgen Inc. AMGN | 2 | $42.65 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $40.67 |
| Mallinckrodt Hospital Products Inc. | 2 | $40.57 |
| Calliditas Therapeutics US Inc. | 2 | $37.09 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.